Integrative Cancer Care
Dr. Ford was led towards integrative cancer care through a very close, personal experience with the illness and he now has a special interest in the treatment of cancer using diet/lifestyle, nutritional supplements, intravenous therapy, mistletoe therapy, low dose Naltrexone as well as both conventional and alternative lab testing. He has undergone extra training in order to safely and effectively combine natural therapies with conventional treatment options.
Dr. Ford focuses on Integrated Cancer Care which means that he works together with the conventional treatment options of chemotherapy, radiation and surgery in order to increase the effectiveness of these treatments while helping to minimize any side effects that may occur.
Intravenous Vitamin C and Artesunate
Cancer cells lack the enzyme Glucose-6-phoshate dehydrogenase (G6PD) which converts Vitamin C to an anti-oxidant. This means that Vitamin C at high dose will create oxidative damage in cancer cells leading to the death of these cells. Normal cells in the body are able to convert Vitamin C to an anti-oxidant using G6PD and they remain intact.
Using an extract known as Artesunate from the herb, Artemisia annua (Wormwood) in combination with the high dose intravenous Vitamin C increases the oxidative stress that is put on the cancer cells. These work synergistically to increase the effectiveness of the treatments.
High dose intravenous Vitamin C has been shown to increase the efficacy and effectiveness of certain chemotherapeutic drugs and improve the overall quality of life for cancer patients.
Mistletoe Therapy
White-berried European mistletoe or Viscum album has been a successful remedy for advanced cancer since 1917. Approximately 79% of German and Swiss medical doctors advise their cancer patients to use it. Mistletoe lectins are able to protect DNA, and this is of great utility during chemotherapy and radiation. Mistletoe therapy is commonly prescribed during radiation and chemotherapy in Europe, and is proven to reduce risk of adverse events by half. Patient care costs and loss of productivity costs are reduced by half as well.
Low Dose Naltrexone
Naltrexone at approximately one tenth of the standard dose has been shown to bind opioid receptors leading to increased levels of endorphins and metaenkephalins. Cancer cells use opioid receptors in order to effectively turn off the immune system, but the Naltrexone ultimately balances the function of the immune system so that it is able to work against the cancer cells.
Chemosensitivity and Circulating Tumour Cell Testing
Chemosensitivity and Circulating Tumour Cell (CTC) testing can help guide therapies that will be more specific to the genetic mutations of cancer cells. It is able test the natural agents and chemotherapy drugs that your cancer cells will respond to.
For more information on available testing please see:
https://rgcc-group.com/index.php?page=tests
Dr. Ford focuses on Integrated Cancer Care which means that he works together with the conventional treatment options of chemotherapy, radiation and surgery in order to increase the effectiveness of these treatments while helping to minimize any side effects that may occur.
Intravenous Vitamin C and Artesunate
Cancer cells lack the enzyme Glucose-6-phoshate dehydrogenase (G6PD) which converts Vitamin C to an anti-oxidant. This means that Vitamin C at high dose will create oxidative damage in cancer cells leading to the death of these cells. Normal cells in the body are able to convert Vitamin C to an anti-oxidant using G6PD and they remain intact.
Using an extract known as Artesunate from the herb, Artemisia annua (Wormwood) in combination with the high dose intravenous Vitamin C increases the oxidative stress that is put on the cancer cells. These work synergistically to increase the effectiveness of the treatments.
High dose intravenous Vitamin C has been shown to increase the efficacy and effectiveness of certain chemotherapeutic drugs and improve the overall quality of life for cancer patients.
Mistletoe Therapy
White-berried European mistletoe or Viscum album has been a successful remedy for advanced cancer since 1917. Approximately 79% of German and Swiss medical doctors advise their cancer patients to use it. Mistletoe lectins are able to protect DNA, and this is of great utility during chemotherapy and radiation. Mistletoe therapy is commonly prescribed during radiation and chemotherapy in Europe, and is proven to reduce risk of adverse events by half. Patient care costs and loss of productivity costs are reduced by half as well.
Low Dose Naltrexone
Naltrexone at approximately one tenth of the standard dose has been shown to bind opioid receptors leading to increased levels of endorphins and metaenkephalins. Cancer cells use opioid receptors in order to effectively turn off the immune system, but the Naltrexone ultimately balances the function of the immune system so that it is able to work against the cancer cells.
Chemosensitivity and Circulating Tumour Cell Testing
Chemosensitivity and Circulating Tumour Cell (CTC) testing can help guide therapies that will be more specific to the genetic mutations of cancer cells. It is able test the natural agents and chemotherapy drugs that your cancer cells will respond to.
For more information on available testing please see:
https://rgcc-group.com/index.php?page=tests
